Qingjiang Pharmaceutical Co., Ltd (Jiangsu) is located at Huai’an Economic Development Zone, Jiangsu. It is a medium-sized integrated pharmaceutical enterprise jointly invested by Jiangsu Farms Co., Ltd (Group), Huai’an Hongda Investment Consult Center, Beijing Chia Tai Green Continent Pharmaceutical Co., Ltd and Jiangsu Juxin Investment Management Co., Ltd. The registed captial of the compary is 18.75 million Yuan (RMB). The number of employees is 564, including 183 technicians and professionals, 65 of whom possess medium or high grade professional titles. Our company has strict managerial system, advanced manufacturing establishment and integrated quality assurance system. Our company has successfully passed the first and second term of GMP validations, in 2004 and 2005 respectively, organized by the related food and drug administration bureau, and acquired the authentication certificate. 

Our company has broad spectrum of products from raw material of antibiotics, synthesized bulk pharmaceuticals, Chinese patent medicines and their preparation products, the main dose types of which include drop pill, pill, tablet, capsule, dry suspension and granule. And serial products for curing arthrosis and upper respiratory tract diseases have been produced. We have formed preliminary competitive advantage, the kernel of which is the research and development of joint health products. Our company has a great regard for the R&D of new products. At present, several products are in process of research, and many more projects are planed and prepared. One remarkable product of them is Ruiyi^TM Qingkailing Drop Pill, which has possessed Authentication Number as the first drop pill product in Jiangsu Province.

Having a full backing of the enterprising team of the company leaders, efficient management system, integrated quality control instruments, widespread and efficient marketing team, we value our company of humanity-founded, market-oriented and high technology-instructed. For accurate positioning in the intense market competition, we make great efforts to build up our company as an enterprise producing joint health products with distinct advantage. At the end, what we aim is to reciprocate community with our actual performance.